albendazole has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Connors, WJ | 1 |
| Carson, JA | 1 |
| Chan, WW | 1 |
| Parkins, MD | 1 |
| Kia, EB | 1 |
| Rahimi, HR | 1 |
| Mirhendi, H | 1 |
| Nilforoushan, MR | 1 |
| Talebi, A | 1 |
| Zahabiun, F | 1 |
| Kazemzadeh, H | 1 |
| Meamar, AR | 1 |
2 other studies available for albendazole and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
Albendazole-responsive disseminated Tubulinosema acridophagus in a patient with chronic lymphocytic leukaemia.
Topics: Albendazole; Anti-Infective Agents; Female; Histocytochemistry; Humans; Leukemia, Lymphocytic, Chron | 2017 |
A case of fatal strongyloidiasis in a patient with chronic lymphocytic leukemia and molecular characterization of the isolate.
Topics: Aged; Albendazole; Animals; Anthelmintics; Fatal Outcome; Humans; Ivermectin; Larva; Leukemia, Lymph | 2008 |